260 related articles for article (PubMed ID: 24567801)
1. Hepatitis C virus infection and insulin resistance.
Bose SK; Ray R
World J Diabetes; 2014 Feb; 5(1):52-8. PubMed ID: 24567801
[TBL] [Abstract][Full Text] [Related]
2. Steatosis and insulin resistance in hepatitis C: a way out for the virus?
Del Campo JA; Romero-Gómez M
World J Gastroenterol; 2009 Oct; 15(40):5014-9. PubMed ID: 19859993
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of Hepatitis C Virus-Induced Diabetes Mellitus.
Ashfaq UA; Khalid H
Crit Rev Eukaryot Gene Expr; 2017; 27(4):363-371. PubMed ID: 29283331
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitis.
Basaranoglu M; Basaranoglu G
World J Gastroenterol; 2011 Sep; 17(36):4055-62. PubMed ID: 22039318
[TBL] [Abstract][Full Text] [Related]
5. Importance of hepatitis C virus-associated insulin resistance: therapeutic strategies for insulin sensitization.
Kawaguchi T; Sata M
World J Gastroenterol; 2010 Apr; 16(16):1943-52. PubMed ID: 20419831
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C Virus, Insulin Resistance, and Steatosis.
Kralj D; Virović Jukić L; Stojsavljević S; Duvnjak M; Smolić M; Čurčić IB
J Clin Transl Hepatol; 2016 Mar; 4(1):66-75. PubMed ID: 27047774
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C and insulin resistance: mutual interactions. A review.
Decock S; Verslype C; Fevery J
Acta Clin Belg; 2007; 62(2):111-9. PubMed ID: 17547292
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of IRS-1 by hepatitis C virus infection leads to insulin resistance in a PTEN-dependent manner.
Gao TT; Qin ZL; Ren H; Zhao P; Qi ZT
Virol J; 2015 Feb; 12():12. PubMed ID: 25645159
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus activates the mTOR/S6K1 signaling pathway in inhibiting IRS-1 function for insulin resistance.
Bose SK; Shrivastava S; Meyer K; Ray RB; Ray R
J Virol; 2012 Jun; 86(11):6315-22. PubMed ID: 22457523
[TBL] [Abstract][Full Text] [Related]
10. Branched-chain amino acids and pigment epithelium-derived factor: novel therapeutic agents for hepatitis c virus-associated insulin resistance.
Kawaguchi T; Yamagishi S; Sata M
Curr Med Chem; 2009; 16(36):4843-57. PubMed ID: 19929783
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C as a metabolic disease: Implication for the pathogenesis of NASH.
Koike K
Hepatol Res; 2005 Oct; 33(2):145-50. PubMed ID: 16202646
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3.
Kawaguchi T; Yoshida T; Harada M; Hisamoto T; Nagao Y; Ide T; Taniguchi E; Kumemura H; Hanada S; Maeyama M; Baba S; Koga H; Kumashiro R; Ueno T; Ogata H; Yoshimura A; Sata M
Am J Pathol; 2004 Nov; 165(5):1499-508. PubMed ID: 15509521
[TBL] [Abstract][Full Text] [Related]
13. Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection.
Koike K
J Gastroenterol; 2009; 44 Suppl 19():82-8. PubMed ID: 19148799
[TBL] [Abstract][Full Text] [Related]
14. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus induces a prediabetic state by directly impairing hepatic glucose metabolism in mice.
Lerat H; Imache MR; Polyte J; Gaudin A; Mercey M; Donati F; Baudesson C; Higgs MR; Picard A; Magnan C; Foufelle F; Pawlotsky JM
J Biol Chem; 2017 Aug; 292(31):12860-12873. PubMed ID: 28559285
[TBL] [Abstract][Full Text] [Related]
16. Interaction between hepatitis C virus and metabolic factors.
Kawaguchi Y; Mizuta T
World J Gastroenterol; 2014 Mar; 20(11):2888-901. PubMed ID: 24659880
[TBL] [Abstract][Full Text] [Related]
17. The metabolic regulator PGC-1α links hepatitis C virus infection to hepatic insulin resistance.
Shlomai A; Rechtman MM; Burdelova EO; Zilberberg A; Hoffman S; Solar I; Fishman S; Halpern Z; Sklan EH
J Hepatol; 2012 Oct; 57(4):867-73. PubMed ID: 22732512
[TBL] [Abstract][Full Text] [Related]
18. Diabetes and infections-hepatitis C: is there type 2 diabetes excess in hepatitis C infection?
Naing C; Mak JW; Wai N; Maung M
Curr Diab Rep; 2013 Jun; 13(3):428-34. PubMed ID: 23463119
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus infection: molecular pathways to insulin resistance.
Parvaiz F; Manzoor S; Tariq H; Javed F; Fatima K; Qadri I
Virol J; 2011 Oct; 8():474. PubMed ID: 22008087
[TBL] [Abstract][Full Text] [Related]
20. Endocannabinoid system activation contributes to glucose metabolism disorders of hepatocytes and promotes hepatitis C virus replication.
Sun LJ; Yu JW; Wan L; Zhang XY; Shi YG; Chen MY
Int J Infect Dis; 2014 Jun; 23():75-81. PubMed ID: 24704332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
